AAEMX
Price
$10.78
Change
+$0.07 (+0.65%)
Updated
Dec 20 closing price
RNWFX
Price
$77.72
Change
+$0.12 (+0.15%)
Updated
Dec 20 closing price
Ad is loading...

AAEMX vs RNWFX

Header iconAAEMX vs RNWFX Comparison
Open Charts AAEMX vs RNWFXBanner chart's image
Alger Emerging Markets A
Price$10.78
Change+$0.07 (+0.65%)
VolumeN/A
CapitalizationN/A
American Funds New World R5
Price$77.72
Change+$0.12 (+0.15%)
VolumeN/A
CapitalizationN/A
AAEMX vs RNWFX Comparison Chart
Loading...
View a ticker or compare two or three
VS
AAEMX vs. RNWFX commentary
Dec 24, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AAEMX is a StrongBuy and RNWFX is a Buy.

FUNDAMENTALS
Fundamentals
RNWFX has more cash in the bank: 62.2B vs. AAEMX (18M). RNWFX pays higher dividends than AAEMX: RNWFX (1.51) vs AAEMX (0.00). AAEMX was incepted earlier than RNWFX: AAEMX (14 years) vs RNWFX (23 years). AAEMX is a more actively managed with annual turnover of: 109.60 vs. RNWFX (32.00). RNWFX has a lower initial minimum investment than AAEMX: RNWFX (250) vs AAEMX (1000). AAEMX annual gain was more profitable for investors over the last year : 8.80 vs. RNWFX (5.86). RNWFX return over 5 years is better than : 14.39 vs. AAEMX (7.63).
AAEMXRNWFXAAEMX / RNWFX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence14 years23 years-
Gain YTD7.1894.549158%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets18M62.2B0%
Annual Yield % from dividends0.001.51-
Returns for 1 year8.805.86150%
Returns for 3 years-16.79-5.10329%
Returns for 5 years7.6314.3953%
Returns for 10 years35.7442.6784%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VTRS12.520.39
+3.22%
Viatris
TEO11.890.14
+1.19%
Telecom Argentina SA
DX12.570.14
+1.13%
Dynex Capital
INTT7.680.04
+0.52%
inTEST Corp
VIRX0.21N/A
-1.87%
Viracta Therapeutics